414 related articles for article (PubMed ID: 20670178)
1. Emerging drugs for actinic keratosis.
Ulrich M; Drecoll U; Stockfleth E
Expert Opin Emerg Drugs; 2010 Dec; 15(4):545-55. PubMed ID: 20670178
[TBL] [Abstract][Full Text] [Related]
2. Actinic keratosis: review of the literature and new patents.
Cantisani C; De Gado F; Ulrich M; Bottoni U; Iacobellis F; Richetta AG; Calvieri S
Recent Pat Inflamm Allergy Drug Discov; 2013 May; 7(2):168-75. PubMed ID: 23470197
[TBL] [Abstract][Full Text] [Related]
3. Actinic keratosis: facts and controversies.
Ko CJ
Clin Dermatol; 2010; 28(3):249-53. PubMed ID: 20541675
[TBL] [Abstract][Full Text] [Related]
4. What is the role of field-directed therapy in the treatment of actinic keratosis? Part 2: Commonly used field-directed and lesion-directed therapies.
Berman B; Cohen DE; Amini S
Cutis; 2012 Jun; 89(6):294-301. PubMed ID: 22838095
[TBL] [Abstract][Full Text] [Related]
5. Paclitaxel-loaded ethosomes®: potential treatment of squamous cell carcinoma, a malignant transformation of actinic keratoses.
Paolino D; Celia C; Trapasso E; Cilurzo F; Fresta M
Eur J Pharm Biopharm; 2012 May; 81(1):102-12. PubMed ID: 22414731
[TBL] [Abstract][Full Text] [Related]
6. Pathology and pathobiology of actinic (solar) keratosis - an update.
Roewert-Huber J; Stockfleth E; Kerl H
Br J Dermatol; 2007 Dec; 157 Suppl 2():18-20. PubMed ID: 18067626
[TBL] [Abstract][Full Text] [Related]
7. Safety of topical interventions for the treatment of actinic keratosis.
Koch EAT; Wessely A; Steeb T; Berking C; Heppt MV
Expert Opin Drug Saf; 2021 Jul; 20(7):801-814. PubMed ID: 33834933
[No Abstract] [Full Text] [Related]
8. The many clinico-pathologic faces of actinic keratosis: an atlas.
Massone C; Cerroni L
Curr Probl Dermatol; 2015; 46():64-9. PubMed ID: 25561208
[TBL] [Abstract][Full Text] [Related]
9. Actinic keratosis with atypical basal cells (AK I) is the most common lesion associated with invasive squamous cell carcinoma of the skin.
Fernández-Figueras MT; Carrato C; Sáenz X; Puig L; Musulen E; Ferrándiz C; Ariza A
J Eur Acad Dermatol Venereol; 2015 May; 29(5):991-7. PubMed ID: 25428612
[TBL] [Abstract][Full Text] [Related]
10. [The real face of actinic keratosis: field of cancerisation and squamous cell carcinoma].
Basset-Seguin N
Eur J Dermatol; 2012 Dec; 22 Suppl 1():5-9. PubMed ID: 23269757
[TBL] [Abstract][Full Text] [Related]
11. [Beyond actinic keratoses: Field cancerization of the skin].
Reygagne P; Rostain G
Ann Dermatol Venereol; 2018 Oct; 145(10):587-592. PubMed ID: 30243819
[TBL] [Abstract][Full Text] [Related]
12. Actinic keratosis: precancer, squamous cell carcinoma, or marker of field cancerization?
Deltondo JA; Helm KF
G Ital Dermatol Venereol; 2009 Aug; 144(4):441-4. PubMed ID: 19755947
[TBL] [Abstract][Full Text] [Related]
13. Actinic keratosis and squamous cell carcinoma: clinical and pathological features.
Filosa A; Filosa G
G Ital Dermatol Venereol; 2015 Aug; 150(4):379-84. PubMed ID: 26099352
[TBL] [Abstract][Full Text] [Related]
14. Innovative agents for actinic keratosis and nanocarriers enhancing skin penetration.
Schäfer-Korting M; Höltje M; Korting HC; Höltje HD
Skin Pharmacol Physiol; 2010; 23(1):6-14. PubMed ID: 20090403
[TBL] [Abstract][Full Text] [Related]
15. Progression of actinic keratosis to squamous cell carcinoma revisited: clinical and treatment implications.
Feldman SR; Fleischer AB
Cutis; 2011 Apr; 87(4):201-7. PubMed ID: 21644496
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical comparison of p16 expression in actinic keratoses and squamous cell carcinomas of the skin.
Hodges A; Smoller BR
Mod Pathol; 2002 Nov; 15(11):1121-5. PubMed ID: 12429789
[TBL] [Abstract][Full Text] [Related]
17. [Actinic keratoses].
Hommel T; Szeimies RM
Hautarzt; 2016 Nov; 67(11):867-875. PubMed ID: 27613022
[TBL] [Abstract][Full Text] [Related]
18. PICATO (ingenol mebutate 0.015% and 0.05% gels): a novel treatment for actinic keratosis.
Abramovits W; Oquendo M; Vincent KD; Gupta AK
Skinmed; 2013; 11(2):111-5. PubMed ID: 23745230
[No Abstract] [Full Text] [Related]
19. The depth of follicular extension in actinic keratosis correlates with the depth of invasion in squamous cell carcinoma: implication for clinical treatment.
Fernández-Figueras MT; Saenz-Sardà X; Vargas P; Thompson CT; Carrato C; Puig L; Ferrándiz C; Ariza A
J Eur Acad Dermatol Venereol; 2018 Oct; 32(10):1657-1661. PubMed ID: 29489051
[TBL] [Abstract][Full Text] [Related]
20. The paradigm shift in treating actinic keratosis: a comprehensive strategy.
Stockfleth E
J Drugs Dermatol; 2012 Dec; 11(12):1462-7. PubMed ID: 23377517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
